Regulation of the immune response by epidermal cytokines and neurohormones.

[1]  M. Simon,et al.  alpha-Melanocyte-stimulating hormone induces hapten-specific tolerance in mice. , 1996, Journal of immunology.

[2]  E. Medrano,et al.  Thy‐1 + dendritic cells express truncated form of POMC mRNA , 1995, Experimental dermatology.

[3]  J. Kim,et al.  IL-10 production in cutaneous basal and squamous cell carcinomas. A mechanism for evading the local T cell immune response. , 1995, Journal of immunology.

[4]  T. Luger,et al.  The role of cytokines and neuroendocrine hormones in cutaneous immunity and inflammation , 1995, Allergy.

[5]  S. Beissert,et al.  Inhibition of the induction of delayed-type and contact hypersensitivity by calcitonin gene-related peptide. , 1995, Journal of immunology.

[6]  J. Alcocer-Varela,et al.  Role of interleukin 10 in the B lymphocyte hyperactivity and autoantibody production of human systemic lupus erythematosus , 1995, The Journal of experimental medicine.

[7]  M. Furue,et al.  B7‐1 expression of Langerhans cells is up‐regulated by proinflammatory cytokines, and is down‐regulated by interferon‐γ or by interleukin‐10 , 1995 .

[8]  W. Gliński,et al.  Increased concentration of beta-endorphin in the sera of patients with severe atopic dermatitis. , 1995, Acta dermato-venereologica.

[9]  G. Trinchieri,et al.  IL-12 is expressed and released by human keratinocytes and epidermoid carcinoma cell lines. , 1994, Journal of immunology.

[10]  J. Blalock,et al.  The syntax of immune-neuroendocrine communication. , 1994, Immunology today.

[11]  D. Taub,et al.  Human T lymphocyte chemotaxis and adhesion induced by vasoactive intestinal peptide. , 1994, Journal of immunology.

[12]  S. Cousins,et al.  Immunoreactive vasoactive intestinal peptide contributes to the immunosuppressive activity of normal aqueous humor. , 1994, Journal of immunology.

[13]  Y. Aragane,et al.  In vivo effects of interleukin-10 on contact hypersensitivity and delayed-type hypersensitivity reactions. , 1994, The Journal of investigative dermatology.

[14]  D. Wofsy,et al.  Interleukin 6 promotes murine lupus in NZB/NZW F1 mice. , 1994, The Journal of clinical investigation.

[15]  S. Miescher,et al.  Neuropeptides are potent modulators of human in vitro immunoglobulin E synthesis , 1994, European journal of immunology.

[16]  P. J. Larsen,et al.  Contents of corticotropin-releasing hormone and arginine vasopressin immunoreactivity in the spleen and thymus during a chronic inflammatory stress , 1994, Journal of Neuroimmunology.

[17]  F. Trautinger,et al.  Proopiomelanocortin-derived peptides are synthesized and released by human keratinocytes. , 1994, The Journal of clinical investigation.

[18]  S. Reichlin.  Neuroendocrine-immune interactions. , 1993, The New England journal of medicine.

[19]  T. Luger,et al.  Epidermal Growth Factors and Cytokines , 1993 .

[20]  J. Roche,et al.  Modulation of T lymphocyte function by neuropeptides. Evidence for their role as local immunoregulatory elements. , 1993, Journal of immunology.

[21]  M. Marcinkiewicz,et al.  Ontogeny of the prohormone convertases PC1 and PC2 in the mouse hypophysis and their colocalization with corticotropin and alpha-melanotropin. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[22]  J. Brown,et al.  Substance P selectively activates TNF-alpha gene expression in murine mast cells. , 1993, Journal of immunology.

[23]  S. Grabbe,et al.  Regulation of Langerhans cell function by nerves containing calcitonin gene-related peptide , 1993, Nature.

[24]  F. Trautinger,et al.  Production of Immunosuppressing Melanotropins By Human Keratinocytes a , 1993, Annals of the New York Academy of Sciences.

[25]  J. Bos,et al.  The skin immune system: progress in cutaneous biology. , 1993, Immunology today.

[26]  M. Mortrud,et al.  The cloning of a family of genes that encode the melanocortin receptors. , 1992, Science.

[27]  C. Calvo,et al.  Substance P enhances IL-2 expression in activated human T cells. , 1992, Journal of immunology.

[28]  E. M. Smith,et al.  Immunosuppressive effects of corticotropin and melanotropin and their possible significance in human immunodeficiency virus infection. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[29]  M. Perretti,et al.  α-melanocyte-stimulating hormone reduces interleukin-lβ effects on rat stomach preparations possibly through interference with a type I receptor , 1991 .

[30]  J. Kessler,et al.  Cytokine regulation of substance P expression in sympathetic neurons. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[31]  J. Bienenstock,et al.  Selective modulation of the natural killer activity of murine intestinal intraepithelial leucocytes by the neuropeptide substance P. , 1990, Immunology.

[32]  E. S. Kimball.  Substance P, Cytokines, and Arthritis , 1990, Annals of the New York Academy of Sciences.

[33]  S. Seidenari,et al.  Neuropeptides in skin from patients with atopic dermatitis: an immunohistochemical study , 1990, The British journal of dermatology.

[34]  C. Dinarello,et al.  Alpha melanocyte stimulating hormone inhibits immunostimulatory and inflammatory actions of interleukin 1. , 1986, Journal of immunology.

[35]  T. G. Truscott,et al.  Biologic effects of light 1995 , 1997 .

[36]  A. Catania,et al.  alpha-Melanocyte stimulating hormone in the modulation of host reactions. , 1993, Endocrine reviews.

[37]  D. Wied.  Neuropeptides : basics and perspectives , 1990 .

[38]  A. Giannetti,et al.  Neuropeptide Y-like immunoreactivity in Langerhans cells from patients with atopic dermatitis. , 1990, The International journal of neuroscience.

[39]  J. Lunec,et al.  Alpha-melanocyte-stimulating hormone immunoreactivity in melanoma cells. , 1990, Pathobiology : journal of immunopathology, molecular and cellular biology.